ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2276

Impact of the Healthy Outcomes in Pregnancy with SLE Through Education of Providers (HOP-STEP) Program: A Mixed Methods Approach

Ravyn Njagu1, Amanda Eudy 2, Amanda Snyderman 1, Lisa Criscione-Schreiber 2 and Megan Clowse 2, 1Duke University, Durham, NC, 2Duke University, Durham

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: medical education and Contraception, pregnancy, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Reproductive Issues In Rheumatic Disorders Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: While centers have worked to optimize lupus pregnancy outcomes, additional efforts are required to have a broader impact on lupus pregnancy outcomes. The goal of this educational initiative was to create a multi-dimensional intervention to equip community rheumatologists with the needed skills, attitudes, and confidence to effectively manage contraceptive decisions and improve pregnancy outcomes.

Methods: Design of the HOP-STEP program included a needs assessment followed by development of a comprehensive program using mixed modalities to create lasting practice change. The program included an in-person didactic, a simulated clinical experience, training in use of a comprehensive handout to guide open contraception and pregnancy conversations, and access to a website with additional resources including certified medical education. We assessed program impact using a mixed methods approach.  A survey was emailed to 149 individuals before and after workshop completion. All attendees were invited to be interviewed about their experience integrating HOP-STEP resources into practice.

Results: We analyzed 68 pre-surveys (response rate 46%, 93% women, 66% attending-level rheumatologists) and 55 post-surveys (response rate 37%, 96% women, 64% attending-level rheumatologists). For qualitative analysis, 8 interviews were completed until thematic saturation was achieved.   At program completion, the percentage of providers reporting a systematic approach to preparing a woman with lupus for pregnancy increased from 45.6% to 94.6%; p< 0.0001. When assessed using confidence scale (0=no confidence, 100=high confidence), median provider confidence in helping women with lupus choose appropriate contraception increased from 59 to 89; p< 0.0001 and confidence in choosing pregnancy compatible medications increased from 66 to 91; p< 0.0001.   While participants demonstrated limited change in contraceptive knowledge, an emerging theme was use of the HOP-STEP contraception handout:   “I’m not really comfortable recommending birth control method[s], but it was interesting to see that whole [contraception] chart…it did increase my confidence because I could just cheat and look at it and show [patients] visually.”   After the program more providers correctly identified azathioprine (74% to 98%, p < 0.0001) and tacrolimus (46% to 91%, p < 0.0001) as pregnancy compatible and mycophenolate as teratogenic (84% to 96%, p=0.04). Regarding comparative teratogenicity, a common theme was elucidated by the following quote:   “That Cellcept is as high as it is on the list of drugs that are very bad for fetuses…I didn’t realize that quite as much as I should’ve, everybody knows about methotrexate, but the fact that Cellcept is probably even worse than methotrexate I was not aware of…”

Conclusion: We have demonstrated successful creation and delivery of a new multi-modal educational program, HOP-STEP, that has improved provider confidence, skills, and knowledge in managing women with lupus who desire pregnancy. Providers may now access a unique curriculum and resources that encourage providers and patients to have open and accurate conversations about pregnancy, creating lasting clinical change.


Disclosure: R. Njagu, None; A. Eudy, GSK, 2; A. Snyderman, GSK, 2; L. Criscione-Schreiber, None; M. Clowse, GSK, 2, UCB, 5.

To cite this abstract in AMA style:

Njagu R, Eudy A, Snyderman A, Criscione-Schreiber L, Clowse M. Impact of the Healthy Outcomes in Pregnancy with SLE Through Education of Providers (HOP-STEP) Program: A Mixed Methods Approach [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/impact-of-the-healthy-outcomes-in-pregnancy-with-sle-through-education-of-providers-hop-step-program-a-mixed-methods-approach/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-the-healthy-outcomes-in-pregnancy-with-sle-through-education-of-providers-hop-step-program-a-mixed-methods-approach/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology